澳大利亚临床实验室将最终红利从每股0.7美元提高到0.09美元,收益率为2.87%。 Australian Clinical Labs raises final dividend from $0.07 to $0.09 per share, yielding 2.87%.

澳大利亚临床实验室有限公司(ASX:ACL)将其最后红利从每股0.7美元提高到0.09美元,9月26日向股东的付款定于9月26日,截至该日已记录在案。 Australian Clinical Labs Limited (ASX:ACL) has raised its final dividend from $0.07 to $0.09 per share, with payment set for September 26th to shareholders on record as of that date. 这一增长的结果是股息收益达到2.87%,从9月3日起有股息收益。 The increase results in a dividend yield of 2.87%, with an ex-dividend date of September 3rd. 该公司提供各种病理学服务,包括例行测试和分子遗传学测试。 The company provides a variety of pathology services, including routine tests and molecular genetics testing.